Skip to main content
  • Oral presentation
  • Open access
  • Published:

Etiology and molecular pathogenesis of RA; how can we best use European initiatives to advance our knowledge?

Understanding etiology and molecular pathogenesis of rheumatoid arthritis is key to the development of precise prevention and curative therapy for this disease. Recent progress on how genes and environment interact in causing immune reactions that may induce arthritis in humans as well as in mice, have provided a conceptual basis for the development of new prevention and treatment strategies which need to be different for different subsets of RA. In order to bring this emerging knowledge to the level where basic and clinical academic science can collaborate with industry for rapid development of the potential new therapies, there is a need for closer collaboration between basic and clinical scientists from many centers, and for increased collaboration between industry and academia in translational medicine.

In Europe, both the EU-funded framework programs and the EU and industry funded Innovative Medicine Initiative (IMI) funder programs in rheumatology are geared to accomplishing these goals. This presentation will be concerned both with the scientific basis of these programs and with a descriptions of the challenges and potential promises that these new collaborative programs offer to rheumatology.

Author information

Authors and Affiliations


Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Klareskog, L. Etiology and molecular pathogenesis of RA; how can we best use European initiatives to advance our knowledge?. Arthritis Res Ther 14 (Suppl 1), O3 (2012).

Download citation

  • Published:

  • DOI: